G-CSF and Exenatide Might Be Associated with Increased Long-Term Survival of Allogeneic Pancreatic Islet Grafts

Background Allogeneic human islettransplantation is an effective therapy for the treatment of patients with Type 1 Diabetes(T1D). The low number of islettransplants performed worldwide and the different transplantation protocols used limit the identification of the most effective therapeutic options to improve the efficacy of this approach.